Brown Seaweed Extract Clinically Tested to Support Weight-Management

condition specificweb.jpg

29 Jun 2010 --- The preliminary data highlighted that thanks to ID-alG, only part of ingested food is actually absorbed by the body, which helps to reduce the negative effect of a hypercaloric diet on body weight and body fat gain.

29 Jun 2010 --- ID-alG from BioSerae is made from premium brown algae sourced in the pristine water off the coast of Brittany and provides a natural source of vital nutrients.

A preliminary in vitro study highlighted the properties of ID-alG to inhibit 2 of the main digestive enzymes, the lipase and the amylase, by more than 50%. More recently, an in vivo test was conducted to confirm the weight-management effect of ID-alG in rats subject to obesity induction. Results show that ID-alG helps to reduce by near than 22% the weight gain of rats fed with fat-enriched meals. This study also highlights that ID-alG enables to limit body fat gain usually favoured by fat-enriched meals.

This preliminary data highlighted that thanks to ID-alG, only part of ingested food is actually absorbed by the body, which helps to reduce the negative effect of a hypercaloric diet on body weight and body fat gain.

A monocentric, randomized, placebo controlled in parallel double-blind clinical study was conducted on 60 overweight women, with a daily dose of 400 mg of ID-alG over 2 months. This clinical study confirms the exceptional weight management properties of ID-alG with significant results observed on women with BMI (Body Mass Index) ≤ 30:

• Almost 3kg weight loss:
The study shows a 2.8 kg average weight loss after two months of treatment compared to placebo (+0.9 kg), p=0.047.

• 100% weight-loss = fat loss
The clinical study shows about 3kg fat mass reduction in the ID-alG group compared to +0.94 kg in the placebo group (p=0.038).

• Shaped buttocks & thighs
By decreasing fat and carb assimilation, ID-alG helps to control caloric intake and to reduce fat storage, thus improving the figures: up to 4 cm thighs reduction, and up to 5.8 cm buttocks reduction observed in the ID-alG group.

Furthermore, at the end of the study each volunteer filled in the satisfaction questionnaire and results were more than encouraging:
• 76% of consumers were convinced by the weight management properties of ID-alG.
More than 70% of women included in the ID-alG group, declared that they would like to buy the product and continue to use it, whereas they were only 49% in the placebo group.
• No side effects
Contrary to other weight-management products which mechanisms tend to be similar to the one of ID-alG (inhibition of digestive enzyme), ID-alG is a safe ingredient and does not induce any side effects.
Moreover, transaminases analysis (ASAT and ALAT) were performed at the beginning and at the end of the study. The goal of this blood analysis was to give the proof that ID-alG is a safe product without adverse effects on the liver. The transaminases ALAT and ASAT were not modified by the product ID-alG either.

This clinical study confirms on women the weight management properties of ID-alG. By decreasing fat and carb assimilation, ID-alG helps to control caloric intake, reducing thus body weight and fat storage, without any side effects.

ID-alG refunds a full spectrum of the original seaweeds’ nutritional properties, including many of essential micronutrients. ID-alG is naturally concentrated in minerals and trace elements particularly in iodine which is renowned to play an essential role in energetic metabolism, thermogenesis and fat reduction.

ID-alG helps to naturally control body weight, while mainting well-being and vitality.

ID-alG can be incorporated into dietary supplements or functional food and beverages, as a natural ingredient to support weight management and well-being.
 

Related Articles

Nutrition & Health News

Diets rich in fish and vegetable oils could reduce epileptic seizures

18 Aug 2017 --- For the first time, production of estrogen in the brain has been directly linked to a study to the presence of docosahexaenoic acid (DHA). The findings of a Hiroshima University study could have implications for treating seizures, as it links DHA directly to a reduction in epileptic seizures.

Nutrition & Health News

Kyowa Hakko’s citicoline supplementation may slow glaucoma

18 Aug 2017 --- A 500mg dose of citicoline from Kyowa Hakko Europe (Kyowa) may significantly slow the progression of visual acuity loss due to glaucoma. This is according to a new study by researchers at the Sao Paolo Hospital Eye Clinic at the University of Milan, who followed 41 patients with progressing glaucoma – a disease that damages the optic nerve and can lead to vision problems and blindness – over two years.

Business News

DuPont expands US probiotics pilot facility to improve NPD, delivery times

18 Aug 2017 --- DuPont Nutrition & Health (DuPont) has announced a “substantial upgrade” to its probiotics pilot facility in Madison, Wisconsin, US. The new enhancements will increase its capability for rapidly developing and commercializing new probiotics with decreased time to market. The US$10 million investment allows for increased pace of new product development and significantly improved delivery times on pilot material for clinical trials and customer evaluations, according to DuPont.

Regulatory News

Cutting calories now “critical” to UK childhood obesity strategy

18 Aug 2017 --- The health agency Public Health England (PHE) has shifted its focus away from solely targeting sugar to cutting excess calorie consumption from all sources in its anti-obesity strategy for children in the UK. “A third of children leave primary school overweight or obese and an excess of calories – not just excess sugar consumption – is the root cause of this,” says Duncan Selbie, Chief Executive of PHE. “We will work with the food companies and retailers to tackle this as the next critical step in combating our childhood obesity problem.”

Nutrition & Health News

Walnuts activate brain area that controls appetite, finds study

17 Aug 2017 --- Consuming walnuts activates an area in the brain associated with regulating hunger and cravings. This is according to a first-of-its-kind new brain imaging study by researchers at Beth Israel Deaconess Medical Center (BIDMC), the findings of which, published online in the journal Diabetes, Obesity and Metabolism, reveal for the first time the neurocognitive impact the nuts have on the brain. 

More Articles
URL : http://www.nutritioninsight.com:80/headlines/Brown-Seaweed-Extract-Clinically-Tested-to-Support-Weight-Management.html